[PDF][PDF] Integrative clinical genomics of advanced prostate cancer
Toward development of a precision medicine framework for metastatic, castration-resistant
prostate cancer (mCRPC), we established a multi-institutional clinical sequencing …
prostate cancer (mCRPC), we established a multi-institutional clinical sequencing …
[PDF][PDF] Organoid cultures derived from patients with advanced prostate cancer
…, SF Slovin, SB Solomon, JA Eastham, P Chi, B Carver… - Cell, 2014 - cell.com
The lack of in vitro prostate cancer models that recapitulate the diversity of human prostate
cancer has hampered progress in understanding disease pathogenesis and therapy response…
cancer has hampered progress in understanding disease pathogenesis and therapy response…
Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update
…, SC Rose, R Salem, CT Sofocleous, SB Solomon… - Radiology, 2014 - pubs.rsna.org
Image-guided tumor ablation has become a well-established hallmark of local cancer
therapy. The breadth of options available in this growing field increases the need for …
therapy. The breadth of options available in this growing field increases the need for …
Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay
Background: The epidermal growth factor receptor (EGFR) mutation T790M is reported in
approximately 50% of lung cancers with acquired resistance to EGFR inhibitors and is a …
approximately 50% of lung cancers with acquired resistance to EGFR inhibitors and is a …
A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti–PD-1 agent pembrolizumab
PS Adusumilli, MG Zauderer, I Rivière, SB Solomon… - Cancer discovery, 2021 - AACR
Regional delivery of mesothelin-targeted CAR T-cell therapy followed by pembrolizumab
administration is feasible, safe, and demonstrates evidence of antitumor efficacy in patients …
administration is feasible, safe, and demonstrates evidence of antitumor efficacy in patients …
Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
…, K Curtis, DM Hyman, JC Durack, SB Solomon… - JCO precision …, 2017 - ascopubs.org
Purpose A long natural history and a predominant osseous pattern of metastatic spread are
impediments to the adoption of precision medicine in patients with prostate cancer. To …
impediments to the adoption of precision medicine in patients with prostate cancer. To …
[HTML][HTML] Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with …
…, C Beattie, B Zhao, SB Solomon… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …
(HCC). No randomized trial has demonstrated superiority of chemoembolization compared …
[HTML][HTML] Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed …
AY Helena, CS Sima, J Huang, SB Solomon… - Journal of Thoracic …, 2013 - Elsevier
Background Development of acquired resistance limits the utility of epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitors (TKI) for the treatment of EGFR-mutant lung …
receptor (EGFR) tyrosine kinase inhibitors (TKI) for the treatment of EGFR-mutant lung …
[HTML][HTML] Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières …
Objectives Previous attempts at meta-analysis and systematic review have not provided
clear recommendations for the clinical application of thermal ablation in metastatic colorectal …
clear recommendations for the clinical application of thermal ablation in metastatic colorectal …
Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes—a 10-year experience at a single center
…, MI D'Angelica, WR Jarnagin, SB Solomon… - Radiology, 2016 - pubs.rsna.org
Purpose To identify predictors of oncologic outcomes after percutaneous radiofrequency
ablation (RFA) of colorectal cancer liver metastases (CLMs) and to describe and evaluate a …
ablation (RFA) of colorectal cancer liver metastases (CLMs) and to describe and evaluate a …